Back to list of Priority Setting Partnerships (formerly known as Working Partnerships)
Prostate Cancer
A JLA Priority Setting Partnership
The James Lind Alliance (JLA) has been asked to develop and manage a Priority Setting Partnership for interested patient and clinician organisations within Prostate Cancer.
Initially the approach came from the Prostate Cancer Research Foundation and the Prostate Cancer Support Federation, supported by the Prostate Cancer Charter for Action but the initiative is open to any patient or clinician organisations with an interest in helping to harvest and then prioritise treatment uncertainties in prostate cancer.
An initial "Stakeholder Meeting" was held 10th June which was attended by 26 participants of which 20 represented organisations (97 organisation representatives were invited), who heard presentations (see below) about our plans for the partnership (For a copy of the invitation letter to the stakeholder meeting please click here).
Presentations as follows:
The Prostate Perspective
Priority setting treatment uncertainties in Prostate Cancer together
Collecting and publishing treatment uncertainties
It is not too late to join the partnership. Please see the contacts below. We would also suggest you become an Affiliate of the JLA (Affiliated members) so that you are kept informed of our work through quarterly Newsletters."
A protocol has been created which sets out the aims, objectives and commitments of the Prostate Cancer Priority Setting Partnership (PSP) and the basic roles and responsibilities of the partners therein. To see a copy of the protocol click here
The "Harvesting" stage for collecting treatment uncertainties is now in progress - the survey has now closed, full details of the outcome of the prioritisation process will be published here.
Glossary of terms [PDF}
For more information please contact:
Lester Firkins (lesterfirkins@mac.com)
Chair, JLA Strategy and Development Group
or
Emma Halls (ehalls@thepcrf.org)
Chief Executive,
Prostate Cancer Research Foundation